Utilizing Multi-Agent Reinforcement Learning With Encoder-Decoder Architecture Agents to Identify Optimal Resection Location in GBM Patients
ISEF · 2025 Robotics and Intelligent Machines
Overview
Currently, there is a noticeable lack of AI in the medical field to support doctors in treating heterogenous diseases such as Glioblastoma Multiforme (GBM), which has a five-year survival rate of just 5.1%. This project develops an AI system offering an end-to-end solution by aiding doctors with both diagnosis and treatment planning. In the diagnosis phase, a sequential decision-making framework consisting of 4 classification models (Convolutional Neural Networks and Support Vector Machine) is used. Each model progressively classifies the patient’s brain into increasingly specific categories, with the final step being diagnosis. For treatment planning, a Reinforcement Learning system consisting of 3 generative models is used. First, the resection model analyzes the diagnosed GBM MRI and predicts a possible resection outcome. Second, the radiotherapy model generates an MRI of the brain’s progression after a user-defined number of weeks. Third, the chemotherapy model produces the post-treatment MRI. A survival rate calculator then checks if the generated treatment plan's survival rate is within 15% of the target. If not, a feedback loop using proximal policy optimization iterates over this system until an optimal resection location is identified. When compared to existing solutions, this project found 3 key findings: (1) Using a sequential decision-making framework consisting of 4 small diagnostic models reduced computing costs by 22.28x, (2) Transformers regression capabilities decreased tumor progression inference time by 113 hours, and (3) Applying Augmentations resembling Real-life situations improved overall DICE scores by 2.9%. These results project to increase survival rates by 0.9%, potentially saving ~2,250 lives.
Competition history
- ISEF 2025
Resources
Related projects
ISEF · 2022
Artificial Intelligence Solution for Effective Treatment Planning for Brain Tumor Patients
ISEF · 2026
AIRA: A Patient-Specific, Risk-Weighted Surgical Path Planning and Preclinical Robotic Execution Framework for Maximal Safe Glioma Resection
ISEF · 2024
CereVis: A Novel Multimodal Comprehensive Surgical Assistance System for Brain Tumors Utilizing Machine Learning for Pre-Operative Planning and Intra-Operative Surgery
ISEF · 2024
Predictive Modeling of Brain Tumor Evolution and Anatomical Invasion: A Novel 3D Time Series Forecasting Approach for Enhanced Treatment Planning
Closest projects by meaning, across every fair and year in the corpus.
Source: Regeneron International Science and Engineering Fair